Wei Han
Capital Medical University
6 Papers
9 Citations
Wei Han is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Coronary artery disease. The author has an hindex of 2, co-authored 4 publications. Previous affiliations of Wei Han include Chinese Ministry of Education.
Chat about Author
Papers
The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes.
Meng Chai,Meng Chai,Qingwei Ji,Qingwei Ji,Hai-Tao Zhang,Yujie Zhou,Yujie Zhou,Qing Yang,Qing Yang,Yangwei Zhou,Guangjin Guo,Wei Liu,Wei Liu,Wei Han,Wei Han,Lixia Yang,Lixia Yang,Linlin Zhang,Linlin Zhang,Jing Liang,Jing Liang,Yuyang Liu,Yuyang Liu,Dongmei Shi,Dongmei Shi,Yingxin Zhao,Yingxin Zhao +26 more
TL;DR: This is the first report that IL-37 could attenuate not only atherosclerosis, but also vascular calcification, and may offer a therapeutic potential for the prevention and treatment of calcification and atherosclerotic disease.
51
Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age
Jiayin Sun,Wei Han,Sijing Wu,Shuo Jia,Zhenxian Yan,Yonghe Guo,Yingxin Zhao,Yujie Zhou,Wei Liu +8 more
TL;DR: Wang et al. as discussed by the authors found that HHCY was associated with the presence of acute coronary syndrome (ACS) and the severity of coronary artery stenosis in young adults.
Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study
Jiayin Sun,Wei Han,Sijing Wu,Shuo Jia,Zhenxian Yan,Yonghe Guo,Yingxin Zhao,Yujie Zhou,Xiaoli Liu +8 more
TL;DR: Combination of HHcy and smoking is independently associated with the severity of CAD in young patients ≤35 years of age after adjusting for other traditional confounders.
Transcatheter Aortic Valve Implantation in Sievers Type 0 vs. Type 1 Bicuspid Aortic Valve Morphology: Systematic Review and Meta-Analysis.
Yu Du,Zhijian Wang,Wei Liu,Yonghe Guo,Wei Han,Hua Shen,Shuo Jia,Yi Yu,Kangning Han,Dongmei Shi,Yingxin Zhao,Yujie Zhou +11 more
TL;DR: In this paper, the authors compared procedural and 30-day outcomes after TAVI between type 0 and type 1 BAV, and found that the patients with type 0 BAV had a similar incidence of procedural death (OR = 2.6, 95% CI 0.7-10.7) and increased coronary compromise risk.
4